Triple-combination therapy prevents drug resistance in colorectal cancer cells
Treating colorectal cancer with a trio of targeted drugs reduces the acquisition of drug resistance, in vitro research published in Oncogene shows.
Source: Clinical Pharmacist - Category: Drugs & Pharmacology Source Type: research
More News: Cancer | Cancer & Oncology | Colorectal Cancer | Drugs & Pharmacology | Mergers and Aquisitions